Cargando…

The Role of PPARγ Gene Polymorphisms, Gut Microbiota in Type 2 Diabetes: Current Progress and Future Prospects

Over the past decade, there has been a significant increase in studies investigating the relationship between the polymorphisms of the Peroxisome Proliferator-Activated Receptor gamma (PPARγ) gene and Type 2 Diabetes (T2D). PPARγ, a critical transcription factor, plays a central role in lipid metabo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yi-Kun, Zhu, Xiang-Dong, Liu, Rong, Yang, Xia, Liang, Yong-Lin, Wang, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638901/ https://www.ncbi.nlm.nih.gov/pubmed/37954888 http://dx.doi.org/10.2147/DMSO.S429825

Ejemplares similares

PPAR α and PPAR γ Polymorphisms as risk factors for Dyslipidemia in a Chinese han population
por: Gu, Shu-Jun, et al.
Publicado: (2014)

Current Understanding of the Role of PPARγ in Gastrointestinal Cancers
por: Zou, Bing, et al.
Publicado: (2009)

Current progress and future prospects in phylofloristics
por: Li, Rong, et al.
Publicado: (2018)

Haplotype Analysis of PPARγ Gene Polymorphisms and the Lipoprotein (a) Level
por: SHEN, Chao, et al.
Publicado: (2018)

Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects
por: Li, Jing, et al.
Publicado: (2022)

PPAR-γ Modulators as Current and Potential Cancer Treatments
por: Chi, Tiange, et al.
Publicado: (2021)

The role of PPARγ in prostate cancer development and progression
por: Hartley, Andrew, et al.
Publicado: (2022)

PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008)

Serum PPARγ level and PPARγ gene polymorphism as well as severity and prognosis of brain injury in patients with arteriosclotic cerebral infarction
por: Wei, Weiming, et al.
Publicado: (2018)

PPARγ2(Pro12Ala) Polymorphism and Human Health
por: He, Weimin
Publicado: (2009)

PPARγ Gene Polymorphisms, Metabolic Disorders, and Coronary Artery Disease
por: Song, Yongyan, et al.
Publicado: (2022)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

Gut microbiota-derived inosine from dietary barley leaf supplementation attenuates colitis through PPARγ signaling activation
por: Li, Daotong, et al.
Publicado: (2021)

Gut Microbiota Dysbiosis in Diabetic Retinopathy—Current Knowledge and Future Therapeutic Targets
por: Serban, Dragos, et al.
Publicado: (2023)

PPARγ Pro(12)Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes
por: Vogel, Ulla, et al.
Publicado: (2009)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

Interactions between Host PPARs and Gut Microbiota in Health and Disease
por: Hasan, Arif Ul, et al.
Publicado: (2019)

Exploring the avian gut microbiota: current trends and future directions
por: Waite, David W., et al.
Publicado: (2015)

Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives
por: Liu, Juan, et al.
Publicado: (2022)

Gut microbiota in acute leukemia: Current evidence and future directions
por: Zhou, Yao, et al.
Publicado: (2022)

Phytoalexins: Current Progress and Future Prospects
por: Jeandet, Philippe
Publicado: (2015)

The human gut resistome: Current concepts & future prospects
por: Singh, Shreya, et al.
Publicado: (2019)

PPARγ is dispensable for clear cell renal cell carcinoma progression
por: Sanchez, Danielle J., et al.
Publicado: (2018)

Gut microbiota in perioperative neurocognitive disorders: current evidence and future directions
por: Sun, Yan, et al.
Publicado: (2023)

Current and future research on the association between gut microbiota and breast cancer
por: Liu, Kuan, et al.
Publicado: (2023)

PPARγ, neuroinflammation, and disease
por: Mrak, Robert E, et al.
Publicado: (2004)

Nutraceuticals as Ligands of PPARγ
por: Penumetcha, Meera, et al.
Publicado: (2012)

PPARγ and Cognitive Performance
por: d’Angelo, Michele, et al.
Publicado: (2019)

Obesity-linked phosphorylation of PPARγ by cdk5 is a direct target of the anti-diabetic PPARγ ligands
por: Choi, Jang Hyun, et al.
Publicado: (2010)

Editorial: Gut microbiota as a therapeutic target in neuropsychiatric disorders: current status and future directions
por: Cai, Hualin, et al.
Publicado: (2023)

Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex
por: Lemkul, Justin A., et al.
Publicado: (2015)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008)

Association between PPAR-γ2 gene polymorphisms and diabetic retinopathy risk: a meta-analysis
por: Li, Xue-Feng, et al.
Publicado: (2021)

The C1431T polymorphism of peroxisome proliferator activated receptor γ (PPARγ) is associated with low risk of diabetes in a Pakistani cohort
por: Butt, Huma, et al.
Publicado: (2016)

Uterus transplantation: current progress and future prospects
por: Johannesson, Liza, et al.
Publicado: (2016)

Human gut microbiota and healthy aging: Recent developments and future prospective
por: Kumar, Manish, et al.
Publicado: (2016)

Does Pro(12)Ala Polymorphism Enhance the Physiological Role of PPARγ2?
por: Pereira, A. C., et al.
Publicado: (2013)

Single-Nucleotide Polymorphism of PPARγ, a Protein at the Crossroads of Physiological and Pathological Processes
por: Petrosino, Maria, et al.
Publicado: (2017)

Fecal microbiota transplantation: current clinical efficacy and future prospects
por: Bowman, Kathryn A, et al.
Publicado: (2015)

Therapeutic Implications of PPARγ in Human Osteosarcoma
por: Wagner, Eric R., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_iiq235gvvsqtp6v2ecmd7ht4b1